In this videocast of The Health Edge Mark and John review interventions used in the MEND (Metabolic Enhancement for NeuroDegeneration) Study. This evolving paradigm shift recognizes many metabolic predispositions e.g. high insulin levels and inflammation to be important drivers of Alzheimer’s Disease risk.